Durham’s Quintiles and G1 Therapeutics top market movers

Durham’s Quintiles and G1 Therapeutics top market movers

Big summer for Durham: the baseball Bulls lead the minor league’s International League South division by 14 games, while two pharmaceutical-related companies burned up the stock market last week. Here are the major movers in the Capital Investment Cos./Nottingham Index of Carolinas-based public companies for the week ended Aug. 25. The index includes companies with shares trading for at least $10.

The biggest gainers:

Quintiles (Q) — 7.9% — $98.82 — Durham-based company that helps drug companies launch products and assembles health care data trades near 52-week high. Expects to have $8 billion in sales this year, with pretax profit or about $2 billion.

G1 Therapeutics  (GTHX) — 7.7% — $17.25 – Durham-based developer of anti-cancer drugs followed up with another strong week after soaring 30% in the previous five-day period. The company went public at $15 in May.

Jeld-Wen (JELD) — 6.6% — $29.98— Charlotte-based building products company bought Milliken Millwork Inc., a Sterling Heights, Mich.-based screen and patio door maker with about $90 million in sales. It was Jeld-Wen’s eight acquisition in the last two years.

Biggest decliners:

Ingles Markets (IMKTA) (-7.3%) $24.25 — Grocery stocks got clobbered when Amazon said it would cut prices on many staple items at Whole Foods Market, starting today. Kroger, the owner of Harris Teeter, declined 8%. Black Mountain-based Ingles has declined 35% in the last year.

Denny’s  (DENN)  (-3.5%) $11.69 — On Eclipse Day, diners could eat all of the moon-shaped pancakes they wanted for $4. Shares have gained 12% in the last year.

Click to read...  Nucor to invest $85M in Ohio plant upgrade

Alliance One Internationsl (AOI) (-5.7%) — $11.50  — Morrisville-based tobacco leaf merchant has declined 45% in the last year.  Expects pretax income of more than $165 million and revenue of $1.9 billion this year.

1
Like
Save
Privacy Policy | Terms of Service | Curation Policy | DMCA Policy